Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/03/2005WO2005103260A1 Process for producing dipeptide
11/03/2005WO2005103259A1 Sars-cov nucleocapsid protein epitopes and uses thereof
11/03/2005WO2005103258A1 A plant, its use as a nutraceutical and the identification thereof
11/03/2005WO2005103257A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
11/03/2005WO2005103256A1 Gene encoding gtpase activating protein and gene product thereof
11/03/2005WO2005103255A1 Formylpeptide receptor (fpr) as a target for anti-malignant glioma therapy
11/03/2005WO2005103254A1 UNIVERSAL TARGET SEQUENCES FOR siRNA GENE SILENCING
11/03/2005WO2005103253A1 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
11/03/2005WO2005103252A1 Reagents and methods for isolation of purified rna
11/03/2005WO2005103251A2 Cancer specific promoters
11/03/2005WO2005103250A1 THERAPEUTIC MEDICINE CONTAINING MONOCLONAL ANTIBODY AGAINST FOLATE RECEPTOR BETA (FR-β)
11/03/2005WO2005103249A1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
11/03/2005WO2005103248A1 Mutated glucose dehydrogenase
11/03/2005WO2005103247A1 Oligonucleotide probe
11/03/2005WO2005103246A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005103242A1 Structure of prl-1 protein crystal and the method of crystallization thereof
11/03/2005WO2005103237A1 Method of constructing recombinant herpes simplex virus
11/03/2005WO2005103236A1 A method for proliferating hepatitis c virus by using normal cells
11/03/2005WO2005103229A2 Transgenomic mitochondria, transmitochondrial cells and organisms, and methods of making and using
11/03/2005WO2005103088A1 A single-domain antibody strengthening fusion protein vh-ldp-ae
11/03/2005WO2005103076A2 Erythropoietin protein variants
11/03/2005WO2005103075A1 Transcriptional activators involved in abiotic stress tolerance
11/03/2005WO2005103074A2 Combinatorial protein library screening by periplasmic expression
11/03/2005WO2005102376A1 Preventive/remedy for diabetic nephropathy
11/03/2005WO2005102310A1 Expression of fatty acid desaturases in corn
11/03/2005WO2005102188A1 Electromagnetic treatment apparatus and method
11/03/2005WO2005102057A2 Methods for controlling plant pathogens using n-phosphonomethylglycine
11/03/2005WO2005102041A2 Crustacean expression vector
11/03/2005WO2005102040A1 Tlr ligand and il-1 response-injured animal model
11/03/2005WO2005102039A1 Human retrovirus-sensitive transgenic nonhuman animal cell and human retrovirus-sensitive transgenic nonhuman animal model
11/03/2005WO2005102038A2 Expression of polypeptides in rod outer segment membranes
11/03/2005WO2005102034A2 Regulatory sequences for expressing gene products in plant reproductive tissue
11/03/2005WO2005102033A2 Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
11/03/2005WO2005101968A2 Antisense oligonucleotides against cpla2, compositions and uses thereof
11/03/2005WO2005090568A3 Promoter chain reaction
11/03/2005WO2005084691B1 Method of proliferating precursor cells
11/03/2005WO2005078113B1 Method for producing l-threonine using bacteria belonging to the genus escherichia
11/03/2005WO2005063996A3 Plant activation of insect toxin
11/03/2005WO2005056794A3 Agents for the regulation of transcription via zinc-finger proteins
11/03/2005WO2005056598A3 Laminin-5 modulators and uses thereof
11/03/2005WO2005049850A3 Compositions and methods for systemic nucleic acid sequence delivery
11/03/2005WO2005049839A3 Rna virus-derived plant expression system
11/03/2005WO2005045037A3 RNA INTERFERENCE MEDIATED INHIBITION OF 5-ALPHA REDUCTASE AND ANDROGEN RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2005WO2005039645A3 Sp1 and sp3 targeted cancer therapies and therapeutics
11/03/2005WO2005035718A3 Biderectional promoters for small rna expression
11/03/2005WO2005025590A3 Use of a dg280 protein product for preventing and treating metabolic disorders
11/03/2005WO2005024062A3 Method for the identification of attenuating lesions in pathogens
11/03/2005WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
11/03/2005WO2005021586A3 Metabolic engineering of viomycin biosynthesis
11/03/2005WO2005019433A3 VIRALLY-ENCODED RNAs AS SUBSTRATES, INHIBITORS AND DELIVERY VEHICLES FOR RNAi
11/03/2005WO2005017159A3 Microbial production of l-ascorbic acid
11/03/2005WO2005014790A3 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same
11/03/2005WO2004065620B1 Modulation of thyroid hormone receptor interactor 3 expression
11/03/2005WO2004060909A3 Increasing production of proteins in gram-positive microorganisms
11/03/2005WO2004057016A3 METHODS OF CAPTURING, DETECTING AND QUANTIFYING RNA:DNA HYBRIDS AND A MODIFIED RNase H USEFUL THEREIN
11/03/2005WO2003062173A8 Alanine 2,3- aminomutase
11/03/2005WO2003000842A3 Novel proteins and nucleic acids encoding same
11/03/2005US20050246801 Seed of cotton cultivar produced by crossing the cotton DP 455 BG/RR with itself or another cotton line
11/03/2005US20050246799 Receptors for hypersensitive response elicitors and uses thereof
11/03/2005US20050246798 Novel glyphosate-N-acetyltransferase (GAT) genes
11/03/2005US20050246797 Gene participating in the synthesis of brassinosteroid
11/03/2005US20050246796 Dominant gene suppression transgenes and methods of using same
11/03/2005US20050246795 Root-specific expansin gene regulating root growth and obstacle-touching stress resistance in the plant
11/03/2005US20050246794 Functional and hyperfunctional siRNA
11/03/2005US20050246793 Plant starch composition
11/03/2005US20050246792 Method for improving corn starch extractability
11/03/2005US20050246791 Animal feed with low phytic acid, oil burdened and protein laden grain
11/03/2005US20050246788 Self-incompatible transgenic plants
11/03/2005US20050246787 Globulin-1 regulatory region and method of using same
11/03/2005US20050246786 Method and apparatus for substantially isolating plant tissues
11/03/2005US20050246785 Promoter, promoter control elements, and combinations, and uses thereof
11/03/2005US20050246784 Method for identifying herbicidally active substances
11/03/2005US20050246782 Transgenic aves producing human polyclonal antibodies
11/03/2005US20050246781 Transgenic production in saliva
11/03/2005US20050246780 Phytases, nucleic acids encoding them and methods for making and using them
11/03/2005US20050246566 Process for providing submodel performance in a computer processing unit
11/03/2005US20050245733 contacting a nucleic acid solution with glucosides, then with a binding matrix, then washing the binding matrix to obtain purified nucleic acids
11/03/2005US20050245732 Nucleotide sequences coding plant transcription factor for use as tools in heterologus gene expression; tissue engineering;
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245564 Methods and compositions related to IRM compounds and toll-like receptor pathways
11/03/2005US20050245475 Functional and hyperfunctional siRNA directed against Bcl-2
11/03/2005US20050245474 Double stranded constructs comprising one or more short strands hybridized to a longer strand
11/03/2005US20050245473 Proliferation- and differentiation-modulating agents and uses therefor
11/03/2005US20050245472 Engineered rnai adenovirus silencing expression (erase) of dna reair proteins
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245450 Method of screening a compound for anxiolytic activity in an apolipoprotein E knockout animal
11/03/2005US20050245446 Materials for the delivery of biologically-active material to cells
11/03/2005US20050245443 Bacteria strain and bacteriocin produced therefrom
11/03/2005US20050245437 Peptides having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs
11/03/2005US20050245417 Gram-positive microorganism comprising deletion mutant in metallo-protease gene for use as bioreactor in identifying novel metalloenzymes for textile treatment, cleaning products and enhancing digestibility of animal feeds
11/03/2005US20050244971 Transgenic plants with enhanced stress tolerance
11/03/2005US20050244970 Stem cell libraries
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244968 polynucleotides that encode plant transcription factors; using such constructs in modulating the expression of endogenous and/or heterologous genes; transgenic plants; modifying plant phenotypes
11/03/2005US20050244947 production of a clear extra-chromosomal nucleic acid containing lysate from a cell solution by separating unwanted cellular components (e.g. cell debris, proteins, genomic DNA) in a gentle and non-disruptive manner by flotation
11/03/2005US20050244942 Adeno-associated virus; lysis, elution, ultrafiltration; gene therapy; chromatography
11/03/2005US20050244941 Process for producing levodione
11/03/2005US20050244939 Variant aldolase and processes for producing an optically active IHOG and an optically active monatin using the same